Phoenix/Scottsdale, AZ

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 77%
3. Survival 64%
4. Multiple Myeloma 59%
5. Migraine Disorders 48%
6. Colorectal Neoplasms 42%
7. Lung 41%
8. Transplants 39%
9. Radiotherapy 39%
10. Biopsy 34%
11. Liver Transplantation 33%
12. Mutation 31%
13. Breast Neoplasms 31%
14. Primary Myelofibrosis 30%
15. Eosinophils 29%
16. Genes 28%
17. Safety 28%
18. Recurrence 28%
19. Confidence Intervals 27%
20. Neoplasm Metastasis 26%
21. Drug Therapy 26%
22. Guidelines 25%
23. Population 25%
24. Placebos 24%
25. Mortality 23%
26. Pancreatic Neoplasms 23%
27. Headache 23%
28. Magnetic Resonance Imaging 23%
29. Kidney 23%
30. Stroke 22%
31. Brain 22%
32. Clinical Trials 22%
33. Adenocarcinoma 21%
34. T-Lymphocytes 21%
35. Proteins 21%
36. Hemorrhage 21%
37. Tomography 20%
38. Liver 20%
39. Quality of Life 20%
40. Equipment and Supplies 20%
41. Cognitive Dysfunction 20%
42. Prostatic Neoplasms 19%
43. Infections 19%
44. Polyps 19%
45. Alzheimer Disease 19%
46. Incidence 18%
47. Physicians 18%
48. Bone Marrow 18%
49. Endoscopy 18%
50. Idiopathic Pulmonary Fibrosis 17%
51. Cholecystokinin Receptors 17%
52. Systematic Reviews 17%
53. Pharmaceutical Preparations 17%
54. Pathology 17%
55. Non-Small Cell Lung Carcinoma 17%
56. Fibrosis 16%
57. Thorax 16%
58. Biomarkers 16%
59. Interstitial Lung Diseases 16%
60. Pain 16%
61. Randomized Controlled Trials 16%
62. Atrial Fibrillation 15%
63. Progression-Free Survival 15%
64. Transplantation 15%
65. Carcinoma 15%
66. Radiation 15%
67. Echocardiography 15%
68. Wounds and Injuries 15%
69. Tissue Donors 15%
70. Colonoscopy 15%
71. Transplant Recipients 15%
72. Odds Ratio 15%
73. secretin receptor 15%
74. Robotics 15%
75. Proton Therapy 15%
76. Aneurysm 15%
77. Melanoma 15%
78. Ligands 15%
79. Neuromyelitis Optica 14%
80. Blood Vessels 14%
81. Coccidioidomycosis 14%
82. Epilepsy 14%
83. Technology 14%
84. Costs and Cost Analysis 14%
85. Elderly 14%
86. Inflammation 14%
87. Heart 14%
88. Glioblastoma 13%
89. Meta-Analysis 13%
90. gemcitabine 13%
91. Allografts 13%
92. Lymphoma 13%
93. Serum 13%
94. Peptides 13%
95. Radiology 13%
96. Databases 13%
97. Skin 13%
98. B-Lymphocytes 13%